Faculty Directory Alphabetical

	A. Paige Adams, D.V.M., Ph.D. Immunopathology and infectious disease pathogenesis of alphaviruses in rodent, equine, and non-human primate animal models.
	Marjan Afrouzian, M.D. Diabetic nephropathy; podocyte injury and proteinuria; mechanisms of rejection in organ transplantation (kidney, liver, lung, heart, pancreas)
	Patricia V. Aguilar, Ph.D. My main research interest is to better understand the mechanisms that enable emerging viruses to evade host immune responses and cause disease, and to identify cellular factors that contribute to viral infection.
	Ahmed El-Sayed Ahmed, Ph.D. In the past three decades my colleagues and I focused our research efforts on the impact of chemicals in the environment on human health and its mechanisms.
	Jack B. Alperin, M.D., F.A.C.P. The clinical investigation of problems related to benign diseases of the blood (e.g. hemostasis & thrombosis, hemoglobinopathies, anemia, thrombocytopenia).
	Shakeel Ansari, Ph.D. Xenobiotic metabolism, conjugation, and toxicity; biomonitoring.
	Judith F. Aronson, M.D. Pathogenesis of arenavirus disease.
	Alan Barrett, Ph.D. Molecular basis of attenuation, virulence, and immunogenicity of flaviviruses
	Paul J. Boor, M.D. I am interested in how the larger blood vessels of the body are injured by toxic chemicals in our environment.
	Nahal Boroumand, M.D. Dr. Boroumand’s primary area of interest is general surgical pathology with a special interest in pulmonary and mediastinal pathology.
	Donald H. Bouyer, Ph.D. Pathogenesis and host response mechanisms of rickettsial diseases
	Barbara Jean Bryant, MD, FCAP, FASCP Areas of research include assuring optimal iron balance in volunteer blood donors, hemoglobinopathies, sickle trait donor units, and granulocytapheresis concentrates.
	Alexander A. Bukreyev, Ph.D. Filoviruses Ebola and Marburg, the H5N1 highly pathogenic avian influenza viruses, vectored vaccines, mucosal immunization, immuno-pathogenesis, immune response, reverse genetics.
	Gerald A. Campbell, M.D., Ph.D. Pathologic mechanisms of blood-brain barrier injury in systemic and central nervous system diseases.
	Yingzi Cong, Ph.D. Crohn’s disease and ulcerative colitis are the two major disease entities of inflammatory bowel disease (IBD).
	Robert Allen Cox, Ph.D. Airway structure and function, airway inflammation and disease
	Jianli Dong, M.D., Ph.D. (1) BRAF/MEK/ERK and p16/CDK/RB pathways in cancer biology. (2) Molecular diagnostics and translation research. Research and development of molecular biomarkers in clinical application.
	Mahmoud A. Eltorky, M.D., Ph.D. Lung cancer is the leading cause of cancer death in men and women accounting for 157,200 deaths in 2003 and corresponding to 28% of all cancer deaths. Specifically lung cancer causes 88,400 (31%) deaths in men and 68,800 (25%) deaths in women.
	Perenlei Enkhbaatar, M.D., Ph.D. Pathophysiology of cardiopulmonary morbidity due to multiple traumas such as sepsis, smoke inhalation and cutaneous burn.
	Eduardo Eyzaguirre, M.D. Viral Determinants of Hantavirus Pulmonary Disease in the Hamster.
	Rong Fang, M.D., Ph.D. Dr. Fang’s research interests focus on understanding of the immune regulatory mechanisms involved in the inability of the host defense system to control systemic infection with intracellular bacteria, such as rickettsiae.
	Naomi L. Forrester, Ph.D. Virus evolution using both experimental infections and phylogenetics
	Vicki S. Freeman, Ph.D., MT(ASCP)SC My goal is to provide leadership in clinical laboratory science education across the nation. I believe that it is important to provide quality laboratory practitioners for clinical laboratories.
	Alexander N. Freiberg, Ph.D. One main research interest is in understanding the molecular mechanisms by which emerging RNA viruses cause encephalitis and hemorrhagic fever diseases.
	Charles F. Fulhorst, D.V.M., Dr.P.H. Epidemiology and ecology of rodent-borne hantaviruses and arenaviruses.
	Nisha Jain Garg, Ph.D. Molecular mechanisms essential for maintaining the host-parasite interactions of the development of Trypanosoma cruzi.
	Benjamin B. Gelman, M.D., Ph.D. Mechanisms of HIV- and AIDS-associated neurocognitive, neuropathic, and myelopathic changes.
	Bin Gong, M.D., Ph.D. My research focus is to develop post-transcriptional or translational regulation strategies to protect endothelial cells during infection with intracellular pathogens.
	Joy A. Grise, M.Sc. Causes of stillbirth
	Meihua Guo, M.D. Cytopathology and Surgical Pathology
	Hal K. Hawkins, M.D., Ph.D. Acute inflammatory reaction to tissue injury; wound healing and smoke inhalation injury.
	Tetsuro Ikegami, Ph.D. Our lab uses a well-established reverse genetics system of RVFV MP-12, and currently studies on the immunological significance of MP-12 NSs as a vaccine, as well as the detailed mechanisms of RVFV NSs multifunctions.
	Alexander J. Indrikovs, M.D. our study titled "Decision assist and closed loop resuscitation of hemorrhage in humans" is testing emerging new monitoring technologies for combat casualty care in volunteers undergoing a 10 mL/kg controlled hemorrhage.
	Bhupendra Singh Kaphalia, Ph.D. Lipid conjugation of xenobiotic alcohols and mechanisms of their toxicity.
	M. Firoze Khan, Ph.D. Oxidative stress and autoimmune diseases.
	Mike Loeffelholz, Ph.D., ABMM Diagnostic virology and microbiology.
	Jere W. McBride, Ph.D. Obligate intracellular bacteria pathobiology, host response, diagnostics, and vaccine development.
	Shinji Makino, D.V.M., Ph.D. Molecular virology and pathogenesis of SARS-coronavirus and Rift Valley fever virus
	Nobby C. Mambo, M.D. Medical student and post-graduate medical education.
	Vladimir L. Motin, Ph.D. Currently, my major research interest is the pathogenesis of Yersinia pestis, the etiological agent of plague.
	Frederick A. Murphy, Ph.D. The virology, pathology and epidemiology of highly pathogenic viruses/viral diseases
	Ranjana S. Nawgiri, M.D. Fine needle aspiration cytology.
	Anthony O. Okorodudu, Ph.D., MBA, SC (ASCP), NRCC (TOXI), DABCC, FACB Intracellular cations with respect to cell membrane changes in aging.
	Juan P. Olano, M.D. Pathogenesis of rickettsial and ehrlichial infections.
	Slobodan Paessler, D.V.M., Ph.D. My research has focused on viral pathogenesis and vaccine/diagnostics/antivirals development.
	C.J. Peters, M.D. Main interests are the pathogenesis and epidemiology of viral diseases and the genetics of host resistance.
	John R. Petersen, Ph.D. My research focuses on development of new clinical methodologies and the analytical validation of these methods.
	Vsevolod Leonidovich Popov, Ph.D., D.Sc. Ultrastructure of viruses and intracellular bacteria and their interactions with host cells.
	You-Wen Qian, M.D., Ph.D. Diagnosis of benign and malignant hematopoietic diseases using various approaches including flow cytometry immunophenotyping; Pathology Informatics, especially in laboratory information handling and clinical decision support.
	Suimmin Qiu, M.D., Ph.D. My research interests are focused on cancer molecular biology and cancer pathogenesis.
	Bill A. Rampy, D.O., Ph.D. My career goals in Pathology Education are driven by keen interests in the domains of digital imaging, pathology informatics and online learning.
	Barry Rockx, Ph.D. Dr. Rockx’s research interests are focused on virus-host interactions, molecular pathogenic mechanisms, and the host responses following emerging high containment virus infection.
	Sanjeev K. Sahni, Ph.D. The obligate intracellular bacteria belonging to Rickettsia species are etiological agents of the spotted fever and typhus groups (SFG and TG) of rickettsial diseases in almost all geographic locations worldwide.
	Vicki Jeanne Schnadig, M.D. I am a service and teaching-oriented pathologist with nearly 20 years experience in diagnostic gynecologic and nongynecologic cytology.
	Elena Sbrana, M.S., Ph.D. Autopsy pathology, infectious diseases pathology, pulmonary pathology.
	Lynn Soong, M.D., Ph.D. Protective immunity and pathogenesis of intracellular pathogens; Dendritic cell-pathogen interactions; T cell priming; Cytokines/Chemokines; Vaccine development
	L. Clarke Stout, M.D. Studies of diabetic renal glomerular disease in humans.
	Robert B. Tesh, M.D. Anthropod-borne and rodent-associated viral diseases; leishmaniosis; vector biology.
	Saravanan Thangamani, Ph.D. My research interests are focused on to elucidate the Pathogen-Vector(ticks and mosquitoes)-Host Interface.
	Alfredo G. Torres, Ph.D. Shiga toxin-producing strains of enterohemorrhagic Escherichia coli (EHEC) are a class of pathogenic E. coli responsible for numerous food- and water-borne outbreaks causing a range of illness in humans, from non-bloody diarrhea to hemorrhagic colitis or hemolytic uremic syndrome (HUS).
	Smita Vaidya, Ph.D. Recognition of HLA epitopes by HLA antibodies.
	Gustavo Valbuena, M.D., Ph.D. Investigation of endothelium-target pathogens, particularly rickettsiae, and the immune mechanisms of endothelial cells lining the vascular system.
	Nikos Vasilakis, Ph.D. Basic research on evolution and pathogenesis of arthropod-borne viruses, virus – mosquito, virus – host interactions and vaccine development.
	David H. Walker, M.D. Pathobiology of obligate intracellular pathogens.
	Gangduo Wang, M.D., Ph.D. Experimental models and mechanisms of chemical-induced autoimmunity.
	Tian Wang, Ph.D. My research focuses on understanding of immune response to West Nile virus infection in protection and pathogenesis.
	Scott C. Weaver, Ph.D. Pathogenesis, epidemiology, and evolution of arboviruses; arbovirus-vector interactions.
	Natalie Williams-Bouyer, Ph.D. Antimicrobial resistance trends.
	Paul H. Xue, M.D. Teaching of grossing in surgical pathology.
	Xue-jie Yu, M.D., Ph.D. Pathogenesis of obligately intercellular bacteria and the mechanism of persistent ehrlichial infection.
	Nadezhda E. Yun, M.D. Bolecular biology, viral pathogenesis, vaccines/antivirals, and diagnostics development.

This site published by The Department of Pathology
Copyright © The University of Texas Medical Branch. Please review our site policies and required links